These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12209678)

  • 1. Hormone replacement therapy and breast carcinoma risk in Hispanic and non-Hispanic women.
    Li R; Gilliland FD; Baumgartner K; Samet J
    Cancer; 2002 Sep; 95(5):960-8. PubMed ID: 12209678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density.
    Hou N; Hong S; Wang W; Olopade OI; Dignam JJ; Huo D
    J Natl Cancer Inst; 2013 Sep; 105(18):1365-72. PubMed ID: 24003037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family history and risk of breast cancer in hispanic and non-hispanic women: the New Mexico Women's Health Study.
    Li R; Gilliland FD; Baumgartner KB; Samet J
    Cancer Causes Control; 2001 Oct; 12(8):747-53. PubMed ID: 11562115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?
    Roy JA; Sawka CA; Pritchard KI
    J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk: effects of estrogen replacement therapy and body mass.
    Harris RE; Namboodiri KK; Wynder EL
    J Natl Cancer Inst; 1992 Oct; 84(20):1575-82. PubMed ID: 1404451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
    Gapstur SM; Morrow M; Sellers TA
    JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Ross RK; Paganini-Hill A; Wan PC; Pike MC
    J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
    Lemay A
    J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study on women with a history of breast cancer and with or without estrogen replacement therapy.
    Marttunen MB; Hietanen P; Pyrhönen S; Tiitinen A; Ylikorkala O
    Maturitas; 2001 Sep; 39(3):217-25. PubMed ID: 11574181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive risk factors for breast cancer in Hispanic and non-Hispanic white women: the New Mexico Women's Health Study.
    Gilliland FD; Hunt WC; Baumgartner KB; Crumley D; Nicholson CS; Fetherolf J; Samet JM
    Am J Epidemiol; 1998 Oct; 148(7):683-92. PubMed ID: 9778175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body size throughout adult life influences postmenopausal breast cancer risk among hispanic women: the breast cancer health disparities study.
    John EM; Sangaramoorthy M; Hines LM; Stern MC; Baumgartner KB; Giuliano AR; Wolff RK; Slattery ML
    Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):128-37. PubMed ID: 25352523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives on the Women's Health Initiative trial of hormone replacement therapy.
    Grimes DA; Lobo RA
    Obstet Gynecol; 2002 Dec; 100(6):1344-53. PubMed ID: 12468183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormones and breast cancer: evidence and implications for consideration of risks and benefits of hormone replacement therapy.
    Colditz GA
    J Womens Health; 1999 Apr; 8(3):347-57. PubMed ID: 10326989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer after hormone replacement therapy--does prognosis differ in perimenopausal and postmenopausal women?
    Baumgärtner AK; Häusler A; Seifert-Klauss V; Schuster T; Schwarz-Boeger U; Kiechle M
    Breast; 2011 Oct; 20(5):448-54. PubMed ID: 21652211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy regimens and breast cancer risk(1).
    Weiss LK; Burkman RT; Cushing-Haugen KL; Voigt LF; Simon MS; Daling JR; Norman SA; Bernstein L; Ursin G; Marchbanks PA; Strom BL; Berlin JA; Weber AL; Doody DR; Wingo PA; McDonald JA; Malone KE; Folger SG; Spirtas R
    Obstet Gynecol; 2002 Dec; 100(6):1148-58. PubMed ID: 12468157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal estrogen replacement therapy is associated with adverse breast cancer prognostic indices.
    LeBlanc ES; Viscoli CM; Henrich JB
    J Womens Health Gend Based Med; 1999; 8(6):815-23. PubMed ID: 10495262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and breast cancer: revisiting the issues.
    DeGregorio MW; Taras TL
    J Am Pharm Assoc (Wash); 1998; 38(6):738-44; quiz 744-6. PubMed ID: 9861792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
    Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Cushing-Haugen KL; Daling JR
    JAMA; 2003 Jun; 289(24):3254-63. PubMed ID: 12824206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of Hormone Replacement Therapy Knowledge and Current Hormone Replacement Therapy Use.
    Doamekpor LA; Head SK; South E; Louie C; Zakharkin S; Vasisht K; Bersoff-Matcha S
    J Womens Health (Larchmt); 2023 Mar; 32(3):283-292. PubMed ID: 36459626
    [No Abstract]   [Full Text] [Related]  

  • 20. The risks and benefits of estrogen replacement therapy: Leisure World.
    Paganini-Hill A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():54-62. PubMed ID: 7581589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.